2016 Q3 American Biomedical Technology Company Venture Capital Top 10
According to a quarterly report published by PricewaterhouseCoopers, Thomson Reuters data, in the third quarter of 2016, a total of 891 investment transactions were generated by startups in various industries in the United States, totaling $10.6 billion. Compared with the same period in 2015, it dropped by 25% and 36% respectively. The number of venture capital transactions in the life sciences sector also dropped from 210 in the same period in 2015 to 156, and the total transaction volume decreased from US$3 billion to US$2.49 billion. Subdivided into the biotechnology sector, a total of 87 transactions were generated with a total transaction value of $1.83 billion. Compared with the 125 transactions in the same period of 2015 and the decline of 2.15 billion US dollars. In the medical device sector, a total of 69 transactions were generated with a total transaction value of $663 million. Compared with the 85 transactions in the same period of 2015 and the decrease of 858 million US dollars. The following is the case of the US TOP10 biotechnology company venture capital investment in the third quarter of 2016. NO.1, Moderna Location: Cambridge, MA Main product: mRNA drugs Raised funds: $474 million Investor: Flagship Ventures; two other undisclosed institutions NO.2, Intarcia Therapeutics Location of Company: Boston, MA The main product: the development of a new drug delivery system, the goal is that some chronic diseases only need to be administered 1 or 2 times a year. Raised funds: $184 million Investor: Venrock; undisclosed institution; Luxin Ventures
face mask used for daily protection, with 3 ply non-woven fabric, It can effectively filter droplets and block direct contact between virus and human body. The fabric is breathable and comfortable,it won't cause skin allergy.
We are professional manufacture of medical equipment with 6 years experiance.
The company conscientiously implements the "Regulations on the supervision and administration of medical devices" and other laws and regulations, and adopts a scientific management mode. The company has successively passed the EU CE certification and CFDA "medical device production quality management specification" assessment.
Adhering to the concept of "quality first, integrity-based, continuous change and long-term commitment", the company is committed to providing customers with high-quality, high safety performance products and high-quality services.
Disposible Face Mask,Face Mask With Logo,Face Mask With Designs,Disposable Medical Face Mask Shanghai Rocatti Biotechnology Co.,Ltd , https://www.ljdmedicals.com
